Explainable Machine Learning Models for Alzheimer's Diagnosis Using Routine and Low-Cost Clinical Data
Medrxiv : the Preprint Server for Health Sciences
|July 30, 2026
Summary
This study developed an explainable AI model for early Alzheimer's Disease (AD) diagnosis using routine clinical data. The model shows high accuracy, offering a cost-effective diagnostic alternative.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Diagnostics
Background:
- Alzheimer's Disease (AD) presents a growing global health concern, characterized by progressive neurodegeneration leading to cognitive decline.
- Current diagnostic methods for AD face challenges including long waiting times for specialist evaluation and high costs.
- There is a critical need for rapid, accessible, and cost-effective diagnostic tools for Alzheimer's Disease.
Purpose of the Study:
- To develop and evaluate an explainable deep learning model for diagnosing Alzheimer's Disease (AD).
- To utilize routine, low-cost clinical data for AD diagnosis, including demographics, patient history, and automatically acquirable neuropsychological test results.
- To compare the diagnostic performance of the developed AI models against clinicians under similar data constraints.
Main Methods:
- Analysis of a large dataset from the National Alzheimer's Coordinating Center (167,364 observations, 1,024 features).
- Development of two classification models: a deep neural network and a Light Gradient Boosting Machine.
- Focus on explainable AI to ensure transparency in the diagnostic process.
Main Results:
- The deep neural network achieved 90% accuracy and a 0.96 ROC-AUC.
- The Light Gradient Boosting Machine model reached 90% accuracy with a 0.97 ROC-AUC.
- Both models demonstrated diagnostic performance comparable to, and in some aspects superior to, clinicians.
Conclusions:
- Explainable AI models can effectively diagnose Alzheimer's Disease using readily available clinical data.
- These AI tools offer a promising, cost-effective, and efficient alternative or supplement to traditional diagnostic pathways.
- The study highlights the potential of AI in addressing the diagnostic challenges associated with Alzheimer's Disease.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

